Search your symptoms with MEDgle. You can check your symptoms. It is a medical symptom search allowing you find out what options make sense for you.
CLOSE
PATIENT GPS
patients
healthcare providers
how it works
about
login
edit search
new search
symptoms
diagnoses
physicians
drugs
procedures
close
symptoms
diagnoses
drugs
procedures
physicians
symptom duration
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
gender
male
female
age
1-3
4-11
12-17
18-29
30-50
50+
age
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
calculate
visual
[hide visual search]
search visually
symptoms
|
diagnoses
|
drugs
|
procedures
|
physicians
search symptoms
•
Find causes for your symptoms
•
Discover relevant types of physicians
search diagnoses
•
Understand the details of a diagnosis
•
Learn about relevant tests and treatments
•
Find useful resources on the web
search drugs
•
Learn about different therapeutic drugs
•
Understand what they are used for
•
Know the potential options
search procedures
•
Learn about different diagnostic and therapeutic procedures
•
Understand what they are used for
•
Know the potential options
search physicians
•
Find physicians in your area
•
Understand what they do
•
Get the right help you need
gvhd prophylaxis
reduced results from
147 billion
41 million
6910
8
to ~10 options
options split into images, definition, symptoms, related diagnoses, diagnostic tests, therapies, and medications
what is 'gvhd prophylaxis'?
Definition for gvhd prophylaxis
gvhd prophylaxis is medication used for such diagnoses as: Purine nucleoside phosphorylse deficiency.
diagnoses treated with 'gvhd prophylaxis'
1 - 1 of
1
diagnosis
Purine nucleoside phosphorylse deficiency
type of immunodeficiency with delayed development
web search for:
gvhd prophylaxis and Purine nucleoside phosphorylse deficiency
related procedures when taking 'gvhd prophylaxis'
1 - 1 of
1
procedures
cultured skin fibroblasts for biochemical study
web search for:
gvhd prophylaxis and cultured skin fibroblasts for biochemical study
related medication for 'gvhd prophylaxis'
1 - 5 of
8
drugs
busulfan
web search for:
gvhd prophylaxis and busulfan
cyclophosphamide
web search for:
gvhd prophylaxis and cyclophosphamide
cyclosporine
web search for:
gvhd prophylaxis and cyclosporine
fluconazole
web search for:
gvhd prophylaxis and fluconazole
lymphocyte immune globulin
web search for:
gvhd prophylaxis and lymphocyte immune globulin
methylprednisolone
web search for:
gvhd prophylaxis and methylprednisolone
ntravenous ig (ivig)
web search for:
gvhd prophylaxis and ntravenous ig (ivig)
trimethoprim (tmp)-sulfamethoxazole
web search for:
gvhd prophylaxis and trimethoprim (tmp)-sulfamethoxazole
for more please login, login is free (click to login)
The following are types of physicians relevant for 'gvhd prophylaxis'.
related types of physicians 'family practitioner, genetics specialist, immunologist, internist'
show local physicians
postal code
Find Local
stars represent relevance to topic not rating
more
The results are computer generated suggestions to help you find a physician. MEDgle does not recommend any particular type of physician or claim to be complete or accurate in the providers and specialties suggested.
web search results for 'gvhd prophylaxis'?
Results
1 - 50
- gvhd prophylaxis
eMedicine - Graft Versus Host Disease : Article by Romeo A Mandanas
... what is now known as graft versus host disease (GVHD) as a syndrome called secondary disease to differentiate it from ... Prophylaxis of acute GVHD: 1.5 mg ...
http://www.emedicine.com/med/topic926.htm
www.emedicine.com
-
summary
Graft-versus-host disease - Wikipedia, the free encyclopedia
6 Treatment of GVHD. 7 Investigational therapies for graft-versus ... Methotrexate, cyclosporin A and tacrolimus are common drugs used for GVHD prophylaxis. ...
http://en.wikipedia.org/wiki/GVHD
en.wikipedia.org
-
summary
Aspergillus Infections in Transplant Recipients
GVHD has been identified as the major risk factor for invasive aspergillosis in ... (0.5 to 1.0 mg/kg of body weight/day) for GVHD prophylaxis in allogeneic ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=544171
www.pubmedcentral.nih.gov
-
summary
Acute graft-versus-host disease in thalassaemic marrow transplantation ...
Graft-versus-host disease (GVHD) prophylaxis was cyclosporin, prednisolone and ... Concomitant acute GVHD prophylaxis consisted of the following: ...
http://www.emro.who.int/publications/emhj/0503/05.htm
www.emro.who.int
-
summary
Tacrolimus as prophylaxis for acute graft-versus-h...[Transplantation ...
PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from ... tacrolimus as GVHD prophylaxis for adult ...
http://www.ncbi.nlm.nih.gov/pubmed/17700155?ordinalpos=3&ito...
www.ncbi.nlm.nih.gov
-
summary
Inside:
GVHD prophylaxis ( 27 ). For example, use of cyclosporine GVHD ... Additionally, the immunosuppressive agents used for GVHD prophylaxis and treatment ...
http://www.cdc.gov/mmwr/PDF/rr/rr4910.pdf
www.cdc.gov
-
summary
eMedicine - Graft Versus Host Disease : Article by Phillip Ruiz, Jr
... known as graft versus host disease (GVHD), is a phenomenon that has been ... The best prophylaxis against chronic GVHD is prevention of acute GVHD because de ...
http://www.emedicine.com/PED/topic893.htm
www.emedicine.com
-
summary
CRISP - Computer Retrieval of Information on Scientific Projects ...
Moderate to severe acute GvHD (grades II-IV) occurs in 30-50% of matched related ... of unrelated recipients of unmodified allografts, despite standard prophylaxis. ...
http://crisp.cit.nih.gov/crisp/CRISP_LIB.getdoc?textkey=6797...
crisp.cit.nih.gov
-
summary
The detection of apoptosis in a human in vitro skin explant assay for ...
... 18 However, these positive results are dependent on the type of GVHD prophylaxis. ... donor transplants given cyclosporin plus methotrexate as GVHD prophylaxis. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1769581
www.pubmedcentral.nih.gov
-
summary
Clinical Study: 03-C-0077, A Pilot Study of EPOCH-F/R Induction ...
Clinical Study Summary ... Cyclosporine & Methotrexate GVHD Prophylaxis for Refractory ... To help prevent GVHD, patients will take four doses of ...
http://clinicalstudies.info.nih.gov/detail/B_2003-C-0077.html
clinicalstudies.info.nih.gov
-
summary
Administration of Itraconazole for Antifungal Prophylaxis in Stem Cell ...
... prophylaxis for GVHD were compared in study drug recipients by linear regression ... flu recipients for GVHD prophylaxis.KEYWORDS: Itraconazole; Pharmacological ...
http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102248534.html
gateway.nlm.nih.gov
-
summary
[Clinical investigation on treatment of children l...[Zhongguo Shi Yan ...
PubMed is a service of the U.S. National Library of Medicine that includes over 18 ... [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted ...
http://www.ncbi.nlm.nih.gov/pubmed/18315910
www.ncbi.nlm.nih.gov
-
summary
eMedicine - Graft Versus Host Disease : Article Excerpt by Romeo A Mandanas
... is now known as graft versus host disease (GVHD) as a syndrome called secondary disease to differentiate it ... receiving no GVHD prophylaxis. Older patients ...
http://www.emedicine.com/med/byname/graft-versus-host-disease.htm
www.emedicine.com
-
summary
Influence of T-cell depletion on chronic graft-versus-host disease ...
GVHD prophylaxis included TCD plus cyclosporine (CSA) or unmodified grafts with ... For GVHD prophylaxis, all patients received cyclosporine after transplantation. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...
www.pubmedcentral.nih.gov
-
summary
Genomics|HuGENet|e-Journal|Abstract|Graft vs Host disease
The mission of the National Office of Public Health Genomics is to integrate ... applications of IL-10, such as prophylaxis for GVHD in transplant recipients. ...
http://www.cdc.gov/genomics/hugenet/ejournal/GraftVsHostAbst.htm
www.cdc.gov
-
summary
Allogeneic stem cell transplantation in children w...[Pediatr ...
PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations ... Uniform GvHD prophylaxis was used (rATG, CsA and MTX) ...
http://www.ncbi.nlm.nih.gov/pubmed/18186885
www.ncbi.nlm.nih.gov
-
summary
Prospective evaluation of 2 acute graft-versus-host (GVHD) grading ...
... trial of interleukin 1 receptor antagonist (IL-1RA) for GVHD prophylaxis. ... GVHD prophylaxis was with cyclosporine and short-course methotrexate; some ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...
www.pubmedcentral.nih.gov
-
summary
eMedicine - Bone Marrow Transplantation, Long-Term Effects : Article by ...
Many children are surviving hematopoietic stem-cell transplantation (HSCT) and ... or in those who received GVHD prophylaxis with methotrexate. ...
http://www.emedicine.com/ped/topic2551.htm
www.emedicine.com
-
summary
Risk factors for acute graft-versus-host disease a...[Bone Marrow ...
PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from MEDLINE and ... methotrexate for GVHD prophylaxis. ...
http://www.ncbi.nlm.nih.gov/pubmed/17724440?ordinalpos=4&ito...
www.ncbi.nlm.nih.gov
-
summary
eMedicine - Infections After Bone Marrow Transplantation : Article by ...
Infections After Bone Marrow Transplantation - Infection is the result of a ... Continued prophylaxis (>6 mo) is required in patients with chronic GVHD or ...
http://www.emedicine.com/ped/topic2850.htm
www.emedicine.com
-
summary
Memory CD4+ T cells do not induce graft-versus-host disease
... therefore, receive some type of GVHD prophylaxis either by depletion of T cells ... This GVHD prophylaxis has adverse effects because mature donor T cells play a ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=162285
www.pubmedcentral.nih.gov
-
summary
New approaches for preventing and treating chronic graft-versus-host ...
Choice of donor, graft source, and GVHD prophylaxis ... transplantation that included anti?thymocyte globulin (ATG) for GVHD prophylaxis. ... Chronic GVHD prophylaxis ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1895039
www.pubmedcentral.nih.gov
-
summary
Risk Factors for Late Invasive Aspergillosis (IA) after Allogeneic Stem ...
Pts with GVHD requiring steroids received mold prophylaxis with low dose ampho B ... 5) Prolonged prophylaxis for patients at risk for late IA needs to be studied. ...
http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102264914.html
gateway.nlm.nih.gov
-
summary
eMedicine - Graft Versus Host Disease : Article by Noah S Scheinfeld
Graft versus host disease (GVHD) occurs when immunologically competent cells are ... Prophylaxis for GVHD usually consists of methotrexate (MTX) with or without ...
http://www.emedicine.com/derm/topic478.htm
www.emedicine.com
-
summary
Reduced-intensity conditioning allogeneic transpla...[Biol Blood Marrow ...
PubMed is a service of the U.S. National Library of Medicine that includes over 18 ... mofetil (MMF) as graft-versus-host disease (GVHD) prophylaxis in the ...
http://www.ncbi.nlm.nih.gov/pubmed/18489992?ordinalpos=14&it...
www.ncbi.nlm.nih.gov
-
summary
The Cord Blood Transplantation Study (COBLT)
... disease (GvHD) prophylaxis, indications for the use of cytokines, definitions ... included engraftment, the frequency and severity of acute and chronic GvHD ...
http://www.nhlbi.nih.gov/resources/deca/descriptions/coblt.htm
www.nhlbi.nih.gov
-
summary
Impact of chronic GVHD therapy on the development of squamous-cell ...
... GVHD prophylaxis (including T-cell depletion), dates and severity of ... The major drugs used for prophylaxis and GVHD therapy?in addition to CSP, AZA, ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1895092
www.pubmedcentral.nih.gov
-
summary
Graft-versus-host disease can be separated from graft-versus-lymphoma ...
... most effective approaches to GvHD prophylaxis, T cell depletion of the ... A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=151899
www.pubmedcentral.nih.gov
-
summary
Impact of graft-versus-host disease on survival.
GVHD may at the same time improve survival by decreasing the risk of disease ... of GVHD is also predicted by a number of factors related to GVHD prophylaxis, ...
http://www.ncbi.nlm.nih.gov/pubmed/18503986
www.ncbi.nlm.nih.gov
-
summary
Hepatotoxicity induced by horse ATG and reversed by rabbit ATG: a case ...
... given cyclosporin-A: 2.5 mg/kg IV twice daily as GVHD prophylaxis as well as ... daclizumab and even ATG have also been used in the GVHD prophylaxis [8-12] ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1920517
www.pubmedcentral.nih.gov
-
summary
Disseminated Bocavirus Infection after Stem Cell Transplant | CDC EID
Graft-versus-host disease (GvHD) prophylaxis consisted of a short course of ... Additionally, on day 22, acute GvHD grade I with skin manifestations developed. ...
http://www.cdc.gov/eid/content/13/9/1425.htm
www.cdc.gov
-
summary
Clinical Study: 04-C-0055, Allogeneic HSCT without Preparative ...
Clinical Study Summary Sheet ... To reduce GVHD, this study uses donor immune cells (Th2 cells) ... conventional cyclosporine GVHD prophylaxis, and short ...
http://clinicalstudies.info.nih.gov/detail/A_2004-C-0055.html
clinicalstudies.info.nih.gov
-
summary
A Pilot Study of Antifungal Prophylaxis with Itraconazole (ITRA) in ...
More effective prophylaxis aimed at high-risk Allo-HSCT recipients is needed. ... GVHD developed in 9 patients (75%). Premature withdrawal was mostly due to bad ...
http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102264863.html
gateway.nlm.nih.gov
-
summary
Status of donor-recipient HLA class I ligands and not the KIR genotype ...
... employed for both conditioning and graft-versus-host disease (GVHD) prophylaxis. ... in tailoring the intensity of GVHD prophylaxis and conditioning ...
http://www.ncbi.nlm.nih.gov/pubmed/17950922
www.ncbi.nlm.nih.gov
-
summary
Marked increased risk of Epstein-Barr virus-related complications with ...
During GVHD therapy, patients received antimicrobial, ... CMV serostatus, HLA match, nor GVHD prophylaxis were predictors of EBV-related complications. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1895580
www.pubmedcentral.nih.gov
-
summary
eMedicine - Hematopoietic Stem Cell Transplantation : Article by ...
Definition Hematopoietic stem cell transplantation (HSCT) involves the intravenous infusion of ... Prophylaxis of GVHD is more successful than treatment. ...
http://www.emedicine.com/med/topic3387.htm
www.emedicine.com
-
summary
Graft-Versus-Host Disease: A Surge of Developments
... administered early after transplantation as prophylaxis against GVHD [1] ... prophylaxis shows that T cell depletion is effective for preventing GVHD but ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1913094
www.pubmedcentral.nih.gov
-
summary
Graft-versus-host disease after nonmyeloablative versus conventional ...
Therefore, GVHD incidence, morbidity of skin, liver, and gut, requirements for ... regimens and received CSP plus methotrexate or MMF for GVHD prophylaxis. ...
http://www.ncbi.nlm.nih.gov/pubmed/12663454
www.ncbi.nlm.nih.gov
-
summary
REDUCED INTENSITY CONDITIONING FOR ALLOGENEIC HEMATOPOIETIC CELL ...
... which may have relevance in developing regimens for GVHD prophylaxis. ... ongoing to evaluate new approaches in GVHD prophylaxis to help improve survival. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1829153
www.pubmedcentral.nih.gov
-
summary
Hepatic injury following reduced intensity unrelated cord blood ...
Preparative regimen and GVHD prophylaxis comprised fludarabine/melphalan/total ... Median onsets of CLD, GVHD, and cholangitis lenta were days 37, 40, and 22, ...
http://www.ncbi.nlm.nih.gov/pubmed/17162212?ordinalpos=15&it...
www.ncbi.nlm.nih.gov
-
summary
Transplantation: CCL8 is a potential molecular candidate for the ...
... diverse conditioning regimens and GVHD prophylaxis, and have other variables. ... of 12 Gy TBI and 120 mg/kg CY, and her GVHD prophylaxis was methotrexate. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2288733
www.pubmedcentral.nih.gov
-
summary
Guidelines for Preventing Opportunistic Infections Among Hematopoietic ...
... because of the development of other strategies for GVHD prophylaxis (27) ... example, use of cyclosporine GVHD prophylaxis has become commonplace since its ...
http://www.cdc.gov/MMWR/preview/MMWRhtml/rr4910a1.htm
www.cdc.gov
-
summary
Colon biopsies for evaluation of acute graft-versus-host disease ...
The type of A-GVHD prophylaxis used was post-transplatation cyclosporin A. Group ... A. Colonic biopsy with GVHD- Focal crypt abnormalities (crypt size variation and ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=153523
www.pubmedcentral.nih.gov
-
summary
Transplantation: Unrelated donor bone marrow transplantation for the ...
Two patients were excluded because data on GVHD prophylaxis were not available. ... conditioning regimen and GVHD prophylaxis (fludarabine-based conditioning vs ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1801062
www.pubmedcentral.nih.gov
-
summary
Treatment of donor graft failure with nonmyeloabla...[Bone Marrow ...
PubMed is a service of the U.S. National Library of Medicine that includes over 18 million ... Future studies should include more intense GVHD prophylaxis. ...
http://www.ncbi.nlm.nih.gov/pubmed/17603511?ordinalpos=7&ito...
www.ncbi.nlm.nih.gov
-
summary
Activation-associated phenotype of CD3+ T cells in acute graft-versus ...
GvHD prophylaxis, grading and treatment ... course of methotrexate were used as GvHD prophylaxis in the majority of cases. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1942002
www.pubmedcentral.nih.gov
-
summary
The influence of cyclosporin alone, or cyclosporin and methotrexate, on ...
... methotrexate versus CsA alone for graft-versus-host disease (GvHD) prophylaxis ... Chronic GvHD was more frequent in DC patients, whereas no patient with SMC ...
http://www.ncbi.nlm.nih.gov/pubmed/17173053?dopt=Abstract
www.ncbi.nlm.nih.gov
-
summary
Differential roles of IL-1 and TNF-? on graft-versus-host disease and ...
During acute GVHD, cytokine dysregulation occurs as a consequence of synergistic ... TNF-? and IL-1 are currently in progress as adjuncts to GVHD prophylaxis. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...
www.pubmedcentral.nih.gov
-
summary
IL-11 separates graft-versus-leukemia effects from graft-versus-host ...
... mild (12), making IL-11 an attractive potential adjuvant to GVHD prophylaxis. ... and may serve as an effective adjunct to clinical regimens of GVHD prophylaxis. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=408425
www.pubmedcentral.nih.gov
-
summary
Acute graft-vs-host disease: pathobiology and mana...[Exp Hematol. 2001 ...
PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from ... drug prophylaxis in GVHD is essential ...
http://www.ncbi.nlm.nih.gov/pubmed/11274753
www.ncbi.nlm.nih.gov
-
summary
show more
1
2
Chat with eNurse Kim about 'gvhd prophylaxis' or something else!
quick facts
related diagnosis category
genetic or congenital
immune system
faq/about
|
disclaimer
|
privacy policy
|
terms of service
|
browse
|
beta
|
contact
|
API - Catalyst
MEDgle does not provide medical advice, diagnosis or treatment. Copyright 2006-2012, MEDgle Inc. All Rights Reserved. MEDgle is NOT affiliated with Google. Last Updated: Mar 14, 2012
This site complies to the
HONcode standard for trustworthy health
information:
verify here
.
Invited Sponsor for Communications Conference
Finalist -- search & reference
MEDgle has been selected for the 2009 Best of Business Award in the Medical research